In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
The use of triptans is contraindicated in patients with migraine and a history of ischemic stroke or coronary artery disease, although there’s no substantial evidence that they directly increase the risk for vascular events.
GAPNA discusses how advanced practice practitioners are well-positioned to encourage healthy lifestyles among older adults, to include activities that help attain/maintain lean muscle mass, regardless of BMI, to reduce chronic pain and frailty.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
The American Academy of Pediatrics (AAP) released a policy statement and an accompanying clinical report on identifying and addressing the effects of trauma and stress on children, families, and their health care providers.
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
Panelists at a virtual congressional briefing, including James Kublin, MD, addressed critical questions about new diagnostic technologies, vaccine and treatment development, and the long-term impact of COVID-19 on patients who have recovered from the disease.
Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.
Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
The field of medicine has been plagued by the underrepresentation of African Americans, people of Hispanic heritage, and Native Americans, as well as institutional racism and sexism that have persisted for decades.
In March, the Centers for Disease Control and Prevention launched phase 1c of its COVID-19 vaccine roll-out plan. Diabetes patients and patients with other underlying medical conditions are included on the list. Learn more in this article.
The Guideline Development Group of the WHO agreed that its recommendations on managing chronic pain in children would be based on the principles that access to pain management is a fundamental human right and children have a right to the highest possible standard of health.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
Anna Lembke, MD, discusses how patients who use drugs are affected by the convergence of 2 public health emergencies – increasing overdose rates, and the COVID-19 pandemic – and addresses controversial solutions proposed by other investigators.
To learn more about the overlapping crises of the opioid epidemic and the COVID-19 pandemic, Psychiatry Advisor interviewed pain specialist Paul J. Christo, MD, MBA, the Director of the Multidisciplinary Pain Fellowship Program at Johns Hopkins Hospital in Baltimore, Maryland.
Top osteoarthritis experts as identified by Expertscape are participating in research that will identify methods for prevention, improved diagnosis, and effective treatment of this prevalent condition.
Physicians should remain cognizant that this is a rapidly and continually evolving situation and that, although some regulations are being relaxed as the country reopens, there might be an increase in cases.
Physicians and hospitals have urged the public to seek immediate medical care when needed, with reassurance regarding sound infection control practices that hospitals have implemented in light of the COVID-19 pandemic.
Mitigating the spread of a virus as infectious as SARS-CoV-2 requires having ample and accurate diagnostic tests available. However, in the United States, community transmission began to occur before adequate testing measures could be implemented.
Paul G. Mathew, MD and Steven D. Bender, DDS, uniquely encounter patients with TMD and migraine in their respective practice and offer their insight regarding the diagnosis and management this often overlooked comorbidity.
COVID-19 is one of the most difficult and challenging events of modern times, upending clinicians’ sense of order and control,1 inundating medical facilities with patients and potentially overwhelming the healthcare system in the US.